|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q67289811
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010729.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q67289811
|
|
024
|
|
|
‡a
0000-0003-4249-7177
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q67289811
|
|
100
|
0 |
|
‡a
M García-Ramírez
‡9
ast
|
|
400
|
0 |
|
‡a
Marta Garcia-Ramírez
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
M García-Ramírez
‡c
investigador
‡9
es
|
|
400
|
0 |
|
‡a
M García-Ramírez
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A compartmentalized microfluidic chip with crisscross microgrooves and electrophysiological electrodes for modeling the blood-retinal barrier.
|
|
670
|
|
|
‡a
Author's Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical
|
|
670
|
|
|
‡a
Author's Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.
|
|
670
|
|
|
‡a
Author's Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
|
|
670
|
|
|
‡a
Author's Anomalous costochondral cartilage in fetal anencephaly
|
|
670
|
|
|
‡a
Author's Apolipoprotein A1 is overexpressed in the retina of diabetic patients.
|
|
670
|
|
|
‡a
Author's Association of HMGB1 with oxidative stress markers and regulators in PDR.
|
|
670
|
|
|
‡a
Author's Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells
|
|
670
|
|
|
‡a
Author's Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma
|
|
670
|
|
|
‡a
Author's Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer
|
|
670
|
|
|
‡a
Author's Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.
|
|
670
|
|
|
‡a
Author's Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
|
|
670
|
|
|
‡a
Author's Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice
|
|
670
|
|
|
‡a
Author's Down's syndrome: altered chondrogenesis in fetal rib.
|
|
670
|
|
|
‡a
Author's Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients
|
|
670
|
|
|
‡a
Author's Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells.
|
|
670
|
|
|
‡a
Author's Effects of TGF-beta1 on proliferation and IGFBP-3 production in a primary culture of human fetal epiphyseal chondrocytes (HFEC)
|
|
670
|
|
|
‡a
Author's Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
|
|
670
|
|
|
‡a
Author's Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema
|
|
670
|
|
|
‡a
Author's Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.
|
|
670
|
|
|
‡a
Author's Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
|
|
670
|
|
|
‡a
Author's Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase
|
|
670
|
|
|
‡a
Author's Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
|
|
670
|
|
|
‡a
Author's Genetic determinants of bone mass.
|
|
670
|
|
|
‡a
Author's geoRge: A Computational Tool To Detect the Presence of Stable Isotope Labeling in LC/MS-Based Untargeted Metabolomics.
|
|
670
|
|
|
‡a
Author's Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors
|
|
670
|
|
|
‡a
Author's High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells.
|
|
670
|
|
|
‡a
Author's Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis
|
|
670
|
|
|
‡a
Author's Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.
|
|
670
|
|
|
‡a
Author's Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study
|
|
670
|
|
|
‡a
Author's Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy.
|
|
670
|
|
|
‡a
Author's Measuring permeability in human retinal epithelial cells
|
|
670
|
|
|
‡a
Author's Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy.
|
|
670
|
|
|
‡a
Author's Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
|
|
670
|
|
|
‡a
Author's Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients
|
|
670
|
|
|
‡a
Author's Modulation of chromatin folding by histone acetylation
|
|
670
|
|
|
‡a
Author's Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice
|
|
670
|
|
|
‡a
Author's New pathogenic candidates for diabetic macular edema detected by proteomic analysis.
|
|
670
|
|
|
‡a
Author's Normoalbuminuric type 1 diabetic patients with retinopathy have an impaired tubular response to desmopressin: its relationship with plasma endothelin-1.
|
|
670
|
|
|
‡a
Author's One-step fractionation method for isolating H1 histones from chromatin under nondenaturing conditions
|
|
670
|
|
|
‡a
Author's Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema
|
|
670
|
|
|
‡a
Author's Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity.
|
|
670
|
|
|
‡a
Author's Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy
|
|
670
|
|
|
‡a
Author's Role of the histone "tails" in the folding of oligonucleosomes depleted of histone H1
|
|
670
|
|
|
‡a
Author's Satellite DNAs contain sequences that induced curvature.
|
|
670
|
|
|
‡a
Author's Silymarin prevents diabetes-induced hyperpermeability in human retinal endothelial cells
|
|
670
|
|
|
‡a
Author's SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
|
|
670
|
|
|
‡a
Author's The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.
|
|
670
|
|
|
‡a
Author's Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
|
|
670
|
|
|
‡a
Author's Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
|
|
670
|
|
|
‡a
Author's Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.
|
|
670
|
|
|
‡a
Author's Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth.
|
|
670
|
|
|
‡a
Author's Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
|
|
909
|
|
|
‡a
(orcid) 0000000342497177
‡9
1
|
|
919
|
|
|
‡a
fenofibricacidpreventsretinalpigmentepitheliumdisruptioninducedbyinterleukin1βbysuppressingampactivatedproteinkinaseampkactivation
‡A
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
‡9
1
|
|
919
|
|
|
‡a
fenofibricacidpreventsretinalpigmentepitheliumdisruptioninducedbyinterleukin1βbysuppressingampactivatedproteinkinase
‡A
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase
‡9
1
|
|
919
|
|
|
‡a
fenofibratepreventsthedisruptionoftheouterbloodretinalbarrierthroughdownregulationofnfκbactivity
‡A
Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
‡9
1
|
|
919
|
|
|
‡a
erythropoietinprotectsretinalpigmentepithelialcellsagainsttheincreaseofpermeabilityinducedbydiabeticconditionsessentialroleofjak2pi3ksignaling
‡A
Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.
‡9
1
|
|
919
|
|
|
‡a
erythropoietinisexpressedinthehumanretinaanditishighlyelevatedinthevitreousfluidofpatientswithdiabeticmacularedema
‡A
Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema
‡9
1
|
|
919
|
|
|
‡a
elevationofapolipoproteina1andapolipoproteinhlevelsinthevitreousfluidandoverexpressionintheretinaofdiabeticpatients
‡A
Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
‡9
1
|
|
919
|
|
|
‡a
effectsoftgfbeta1onproliferationandigfbp3productioninaprimarycultureofhumanfetalepiphysealchondrocyteshfec
‡A
Effects of TGF-beta1 on proliferation and IGFBP-3 production in a primary culture of human fetal epiphyseal chondrocytes (HFEC)
‡9
1
|
|
919
|
|
|
‡a
glycogenstorageinthehumanretinalpigmentepitheliumacomparativestudyofdiabeticandnondiabeticdonors
‡A
Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors
‡9
1
|
|
919
|
|
|
‡a
highglucoseconcentrationleadstodifferentialexpressionoftightjunctionproteinsinhumanretinalpigmentepithelialcells
‡A
High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells.
‡9
1
|
|
919
|
|
|
‡a
effectsofhighglucoseconcentrationonthebarrierfunctionandtheexpressionoftightjunctionproteinsinhumanretinalpigmentepithelialcells
‡A
Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells.
‡9
1
|
|
919
|
|
|
‡a
effectofintensiveinsulintherapyonmacularbiometricsplasmavegfanditssolublereceptorinnewlydiagnoseddiabeticpatients
‡A
Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients
‡9
1
|
|
919
|
|
|
‡a
downssyndromealteredchondrogenesisinfetalrib
‡A
Down's syndrome: altered chondrogenesis in fetal rib.
‡9
1
|
|
919
|
|
|
‡a
calciumdobesilatepreventstheoxidativestressandinflammationinducedbydiabetesintheretinaofdbdbmice
‡A
Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice
‡9
1
|
|
919
|
|
|
‡a
identificationofnewpathogeniccandidatesfordiabeticmacularedemausingfluorescencebaseddifferencegelelectrophoresisanalysis
‡A
Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis
‡9
1
|
|
919
|
|
|
‡a
interphotoreceptorretinoidbindingproteinirbpisdownregulatedatearlystagesofdiabeticretinopathy
‡A
Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.
‡9
1
|
|
919
|
|
|
‡a
intravitreoushepatocytegrowthfactorinpatientswithproliferativediabeticretinopathyacasecontrolstudy
‡A
Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study
‡9
1
|
|
919
|
|
|
‡a
lipopolysaccharidebindingproteinandsolublecd14inthevitreousfluidofpatientswithproliferativediabeticretinopathy
‡A
Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy.
‡9
1
|
|
919
|
|
|
‡a
calciumdobesilatepreventsneurodegenerationandvascularleakageinexperimentaldiabetes
‡A
Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
‡9
1
|
|
919
|
|
|
‡a
beneficialeffectsoffenofibrateinretinalpigmentepitheliumbythemodulationofstressandsurvivalsignalingunderdiabeticconditions
‡A
Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.
‡9
1
|
|
919
|
|
|
‡a
bcl2withlossofapoptosisallowsaccumulationofgeneticalterationsapathwaytometastaticprogressioninhumanbreastcancer
‡A
Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer
‡9
1
|
|
919
|
|
|
‡a
bcl2expressionisassociatedwithlymphnodemetastasisinhumanductalbreastcarcinoma
‡A
Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma
‡9
1
|
|
919
|
|
|
‡a
astrocytederivedcytokinescontributetothemetastaticbrainspecificityofbreastcancercells
‡A
Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells
‡9
1
|
|
919
|
|
|
‡a
measuringpermeabilityinhumanretinalepithelialcells
‡A
Measuring permeability in human retinal epithelial cells
‡9
1
|
|
919
|
|
|
‡a
measuringpermeabilityinhumanretinalepithelialcellsarpe19implicationsforthestudyofdiabeticretinopathy
‡A
Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy.
‡9
1
|
|
919
|
|
|
‡a
metabolicfingerprintsofproliferativediabeticretinopathyan1hnmrbasedmetabonomicapproachusingvitreoushumor
‡A
Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
‡9
1
|
|
919
|
|
|
‡a
mitochondrialdnaoxidationandmanganesesuperoxidedismutaseactivityinperipheralbloodmononuclearcellsfromtype2diabeticpatients
‡A
Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients
‡9
1
|
|
919
|
|
|
‡a
modulationofchromatinfoldingbyhistoneacetylation
‡A
Modulation of chromatin folding by histone acetylation
‡9
1
|
|
919
|
|
|
‡a
modulationofmicrogliapolarizationdynamicsduringdiabeticretinopathyindbdbmice
‡A
Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice
‡9
1
|
|
919
|
|
|
‡a
newpathogeniccandidatesfordiabeticmacularedemadetectedbyproteomicanalysis
‡A
New pathogenic candidates for diabetic macular edema detected by proteomic analysis.
‡9
1
|
|
919
|
|
|
‡a
normoalbuminurictype1diabeticpatientswithretinopathyhaveanimpairedtubularresponsetodesmopressinitsrelationshipwithplasmaendothelin1
‡A
Normoalbuminuric type 1 diabetic patients with retinopathy have an impaired tubular response to desmopressin: its relationship with plasma endothelin-1.
‡9
1
|
|
919
|
|
|
‡a
1stepfractionationmethodforisolatingh1histonesfromchromatinundernondenaturingconditions
‡A
One-step fractionation method for isolating H1 histones from chromatin under nondenaturing conditions
‡9
1
|
|
919
|
|
|
‡a
overexpressionofhemopexininthediabeticeyeanewpathogeniccandidatefordiabeticmacularedema
‡A
Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema
‡9
1
|
|
919
|
|
|
‡a
proteomicanalysisofcerebrospinalfluidfromobesewomenwithidiopathicintracranialhypertensionanewapproachforidentifyingnewcandidatesinthepathogenesisofobesity
‡A
Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity.
‡9
1
|
|
919
|
|
|
‡a
proteomicanalysisofhumanvitreousfluidbyfluorescencebaseddifferencegelelectrophoresisdigeanewstrategyforidentifyingpotentialcandidatesinthepathogenesisofproliferativediabeticretinopathy
‡A
Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy
‡9
1
|
|
919
|
|
|
‡a
associationofhmgb1withoxidativestressmarkersandregulatorsinpdr
‡A
Association of HMGB1 with oxidative stress markers and regulators in PDR.
‡9
1
|
|
919
|
|
|
‡a
roleofthehistonetailsinthefoldingofoligonucleosomesdepletedofhistoneh1
‡A
Role of the histone "tails" in the folding of oligonucleosomes depleted of histone H1
‡9
1
|
|
919
|
|
|
‡a
apolipoproteina1isoverexpressedintheretinaofdiabeticpatients
‡A
Apolipoprotein A1 is overexpressed in the retina of diabetic patients.
‡9
1
|
|
919
|
|
|
‡a
satellitednascontainsequencesthatinducedcurvature
‡A
Satellite DNAs contain sequences that induced curvature.
‡9
1
|
|
919
|
|
|
‡a
silymarinpreventsdiabetesinducedhyperpermeabilityinhumanretinalendothelialcells
‡A
Silymarin prevents diabetes-induced hyperpermeability in human retinal endothelial cells
‡9
1
|
|
919
|
|
|
‡a
socs1derivedpeptideadministeredbyeyedropspreventsretinalneuroinflammationandvascularleakageinexperimentaldiabetes
‡A
SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
‡9
1
|
|
919
|
|
|
‡a
anomalouscostochondralcartilageinfetalanencephaly
‡A
Anomalous costochondral cartilage in fetal anencephaly
‡9
1
|
|
919
|
|
|
‡a
angiogenicandantiangiogenicfactorsinproliferativediabeticretinopathy
‡A
Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
‡9
1
|
|
919
|
|
|
‡a
angiogenesisandmalignantmelanomaangiogenesisisrelatedtothedevelopmentofverticaltumorigenicgrowthphase
‡A
Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.
‡9
1
|
|
919
|
|
|
‡a
angiogenesisandmalignantmelanomaangiogenesisisrelatedtothedevelopmentofvertical
‡A
Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical
‡9
1
|
|
919
|
|
|
‡a
compartmentalizedmicrofluidicchipwithcrisscrossmicrogroovesandelectrophysiologicalelectrodesformodelingthebloodretinalbarrier
‡A
A compartmentalized microfluidic chip with crisscross microgrooves and electrophysiological electrodes for modeling the blood-retinal barrier.
‡9
1
|
|
919
|
|
|
‡a
retinalpigmentepitheliumsomethingmorethanaconstituentofthebloodretinalbarrierimplicationsforthepathogenesisofdiabeticretinopathy
‡A
The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.
‡9
1
|
|
919
|
|
|
‡a
topicaladministrationofdpp4inhibitorspreventsretinalneurodegenerationinexperimentaldiabetes
‡A
Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
‡9
1
|
|
919
|
|
|
‡a
topicaladministrationofglp1receptoragonistspreventsretinalneurodegenerationinexperimentaldiabetes
‡A
Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
‡9
1
|
|
919
|
|
|
‡a
topicaladministrationofsomatostatinpreventsretinalneurodegenerationinexperimentaldiabetes
‡A
Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.
‡9
1
|
|
919
|
|
|
‡a
transcriptionfactorsox18isexpressedinhumancoronaryatheroscleroticlesionsandregulatesdnasynthesisandvascularcellgrowth
‡A
Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth.
‡9
1
|
|
919
|
|
|
‡a
vitreouslevelsofvascularendothelialgrowthfactorarenotinfluencedbyitsserumconcentrationsindiabeticretinopathy
‡A
Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
‡9
1
|
|
919
|
|
|
‡a
georgeacomputationaltooltodetectthepresenceofstableisotopelabelinginlcmsbaseduntargetedmetabolomics
‡A
geoRge: A Computational Tool To Detect the Presence of Stable Isotope Labeling in LC/MS-Based Untargeted Metabolomics.
‡9
1
|
|
919
|
|
|
‡a
geneticdeterminantsofbonemass
‡A
Genetic determinants of bone mass.
‡9
1
|
|
996
|
|
|
‡2
LC|nr2005029985
|
|
996
|
|
|
‡2
LC|no2016027878
|
|
996
|
|
|
‡2
ISNI|0000000122534669
|
|
996
|
|
|
‡2
NUKAT|n 2015000711
|
|
996
|
|
|
‡2
LC|no2010188474
|
|
996
|
|
|
‡2
SUDOC|152113894
|
|
996
|
|
|
‡2
BIBSYS|13048784
|
|
996
|
|
|
‡2
BNE|XX1409524
|
|
996
|
|
|
‡2
LC|n 2005066678
|
|
996
|
|
|
‡2
LC|nr 00030590
|
|
996
|
|
|
‡2
LC|no2019042113
|
|
996
|
|
|
‡2
LC|no2011095526
|
|
996
|
|
|
‡2
SUDOC|160115574
|
|
996
|
|
|
‡2
ISNI|0000000044998651
|
|
996
|
|
|
‡2
DNB|1114420514
|
|
996
|
|
|
‡2
BNE|XX5129763
|
|
996
|
|
|
‡2
BNC|981060711803006706
|
|
996
|
|
|
‡2
ISNI|0000000062080529
|
|
996
|
|
|
‡2
BNC|981058528927806706
|
|
996
|
|
|
‡2
LC|no2006097401
|
|
996
|
|
|
‡2
ISNI|0000000040997280
|
|
996
|
|
|
‡2
LC|no2005121578
|
|
996
|
|
|
‡2
NUKAT|nx2023575602
|
|
996
|
|
|
‡2
ISNI|0000000047522624
|
|
996
|
|
|
‡2
PTBNP|1186181
|
|
996
|
|
|
‡2
LC|ns2013001243
|
|
996
|
|
|
‡2
LC|nr2002014323
|
|
996
|
|
|
‡2
LC|no2011115877
|
|
996
|
|
|
‡2
LC|n 2004004404
|
|
996
|
|
|
‡2
BNC|981058610535406706
|
|
996
|
|
|
‡2
NTA|133973115
|
|
996
|
|
|
‡2
NKC|xx0314068
|
|
996
|
|
|
‡2
NTA|183871618
|
|
996
|
|
|
‡2
LC|no2010141143
|
|
996
|
|
|
‡2
BNE|XX1539977
|
|
996
|
|
|
‡2
ISNI|0000000041972800
|
|
996
|
|
|
‡2
BNCHL|10000000000000000092491
|
|
996
|
|
|
‡2
LC|no2008174835
|
|
996
|
|
|
‡2
DNB|122351398
|
|
996
|
|
|
‡2
PTBNP|1725451
|
|
996
|
|
|
‡2
BNF|16769692
|
|
996
|
|
|
‡2
LC|no2019029744
|
|
996
|
|
|
‡2
LC|nr 97016725
|
|
996
|
|
|
‡2
BNF|17071046
|
|
996
|
|
|
‡2
RERO|A026488634
|
|
996
|
|
|
‡2
LC|n 2010045586
|
|
996
|
|
|
‡2
LC|no 98113476
|
|
996
|
|
|
‡2
DNB|1206270780
|
|
996
|
|
|
‡2
SUDOC|275017354
|
|
996
|
|
|
‡2
ISNI|0000000037922288
|
|
996
|
|
|
‡2
BNE|XX1177719
|
|
996
|
|
|
‡2
LC|ns2012004892
|
|
996
|
|
|
‡2
DNB|1298031575
|
|
996
|
|
|
‡2
DNB|132241846
|
|
996
|
|
|
‡2
ISNI|0000000099102349
|
|
996
|
|
|
‡2
BNE|XX1675766
|
|
996
|
|
|
‡2
J9U|987007520750205171
|
|
996
|
|
|
‡2
LC|no2007032430
|
|
996
|
|
|
‡2
DNB|1013155491
|
|
996
|
|
|
‡2
PLWABN|9814000050305606
|
|
996
|
|
|
‡2
ISNI|0000000455081215
|
|
996
|
|
|
‡2
LC|no2011085790
|
|
996
|
|
|
‡2
SUDOC|219502781
|
|
996
|
|
|
‡2
ISNI|0000000120766714
|
|
996
|
|
|
‡2
ISNI|0000000052209421
|
|
996
|
|
|
‡2
ISNI|0000000485639283
|
|
996
|
|
|
‡2
BNCHL|10000000000000000142074
|
|
996
|
|
|
‡2
ISNI|0000000501484972
|
|
996
|
|
|
‡2
ISNI|0000000396250006
|
|
996
|
|
|
‡2
ISNI|0000000071402286
|
|
996
|
|
|
‡2
BNC|981058618048706706
|
|
996
|
|
|
‡2
DNB|1189705443
|
|
996
|
|
|
‡2
SUDOC|234213728
|
|
996
|
|
|
‡2
BNCHL|10000000000000000870274
|
|
996
|
|
|
‡2
ISNI|0000000070805307
|
|
996
|
|
|
‡2
LC|no2015123202
|
|
996
|
|
|
‡2
BNE|XX1541734
|
|
996
|
|
|
‡2
LC|no2009166804
|
|
996
|
|
|
‡2
LC|ns2013002746
|
|
996
|
|
|
‡2
ISNI|0000000027812683
|
|
996
|
|
|
‡2
LC|no2005063338
|
|
996
|
|
|
‡2
LC|no2010001153
|
|
996
|
|
|
‡2
ISNI|0000000118511827
|
|
996
|
|
|
‡2
RERO|A006397765
|
|
996
|
|
|
‡2
LC|no2010155889
|
|
996
|
|
|
‡2
LC|n 2022017272
|
|
996
|
|
|
‡2
BNE|XX5679845
|
|
996
|
|
|
‡2
LC|n 86847357
|
|
996
|
|
|
‡2
LC|no2019176033
|
|
996
|
|
|
‡2
BNC|981058615916706706
|
|
996
|
|
|
‡2
ISNI|0000000054406867
|
|
996
|
|
|
‡2
LC|no2011191139
|
|
996
|
|
|
‡2
LC|ns2017000309
|
|
996
|
|
|
‡2
BNCHL|10000000000000000116003
|
|
996
|
|
|
‡2
LC|no2016007758
|
|
996
|
|
|
‡2
ISNI|0000000076209338
|
|
996
|
|
|
‡2
ISNI|0000000454870669
|
|
996
|
|
|
‡2
ISNI|000000036144269X
|
|
996
|
|
|
‡2
DNB|1056505613
|
|
996
|
|
|
‡2
ISNI|0000000041151447
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
